Novartis Seeks Full Control of Alcon

Expanding and scaling up pharma CDMO facilities

Selecting a cell culture media manufacturer: considerations to reduce risks

INCOG Biopharma: Pedaling towards excellence

Cellares: A disruptive impact on cell therapy